Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2. (Q40277135)

19 September 2017

Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2. (English)

1 reference

multiple endocrine neoplasia

19 September 2017

1 reference

1 reference

Mise N

1

1 reference

19 September 2017

Drosten M

2

1 reference

19 September 2017

Racek T

3

1 reference

19 September 2017

Tannapfel A

4

1 reference

19 September 2017

Pützer BM

5

1 reference

19 September 2017

language of work or name

English

0 references

publication date

22 May 2006

1 reference

19 September 2017

1 reference

19 September 2017

25

1 reference

19 September 2017

50

1 reference

19 September 2017

6637-6647

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209669

19 September 2017

0 references

cites work

The GDNF family: signalling, biological functions and therapeutic value

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

RET tyrosine kinase signaling in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Signal transduction by the JNK group of MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Mutations of the RET proto-oncogene in Hirschsprung's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Inducible dimerization of RET reveals a specific AKT deregulation in oncogenic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

RET and neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

A targeting mutation of tyrosine 1062 in Ret causes a marked decrease of enteric neurons and renal hypoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Cell signalling and gene expression mediated by RET tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

The RET receptor: function in development and dysfunction in congenital malformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Molecular genetics of multiple endocrine neoplasia types 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Regulation of cell fate decision of undifferentiated spermatogonia by GDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Role of Dok1 in cell signaling mediated by RET tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Dysfunction of the RET receptor in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

The GDNF/RET signaling pathway and human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

The long and short isoforms of Ret function as independent signaling complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Current approaches and perspectives in the therapy of medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Characterization of gene expression induced by RET with MEN2A or MEN2B mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

inferred from DOI database lookup

7 January 2021

based on heuristic

Relative expression of the RET9 and RET51 isoforms in human pheochromocytomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209669

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1209669

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference